Heres a breakdown of recent trading of $LFVN stock by insiders over the last 6 months: RAYMOND B GREER sold 8,000 shares for an estimated $161,221 MICHAEL A BEINDORFF sold 5,850 shares for an estimated $114,309 CYNTHIA LATHAM sold 4,450 shares for an estimated $89,089 DARWIN LEWIS has made 3 purchases buying 578 shares for an estimated $7,250 and 0 sales
Now that GLP-1/GIP products have hit the market, several studies have been conducted testing their efficacy
Semaglutide is a GLP-1 receptor agonist, while tirzepatide is both a GIP and GLP-1 receptor agonist
The RAAS in the Pathogenesis and Treatment of Diabetic Nephropathy
TB-500 contributes to post-surgical recovery through multiple mechanisms including enhanced cellular migration to surgical sites, reduced inflammation, and improved tissue flexibility
It can improve blood sugar levels, which is particularly beneficial for individuals with type 2 diabetes